Catalyst Funds Management Pty »

Aldeyra Therapeutics shares owned by Catalyst Funds Management Pty

Quarter-by-quarter ownership of Aldeyra Therapeutics (ALDX) shares owned by Catalyst Funds Management Pty from 13F filings

Historical chart of Catalyst Funds Management Pty investment in Aldeyra Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aldeyra Therapeutics held by Catalyst Funds Management Pty consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aldeyra Therapeutics by Catalyst Funds Management Pty

Quarter filed Position value Share count Share price at filing
2024-12-31 $65k 13k 4.99
2024-03-31 $16k 4.8k 3.27

More positions owned by Catalyst Funds Management Pty

Apple Ordinary Shares (AAPL)
NVIDIA Corp Ordinary Shares (NVDA)
Meta Platforms Ordinary Shares - Class A (META)
Microsoft Corp Ordinary Shares (MSFT)
Xtrackers Hvst CSI 300 China A-Shs ETF Xtrackers Harvest CSI 300 China A-Shares ETF (ASHR)
Rio Tinto Adr (RIO)
News Corp Ordinary Shares - Class B (NWS)
Revolution Medicines Ordinary Shares (RVMD)
Amphenol Corp Ordinary Shares - Class A (APH)
Broadcom Ordinary Shares (AVGO)
CRH Ordinary Shares (CRH)
Alphabet Ordinary Shares - Class C (GOOG)
Paramount Skydance Corp Ordinary Shares - Class B (PSKY)
JPMorgan Chase & Co Ordinary Shares (JPM)
Alphabet Ordinary Shares - Class A (GOOGL)

View all positions for Catalyst Funds Management Pty

Top funds holding Aldeyra Therapeutics

Knoll Capital Management
Perceptive Advisors
BlackRock
Vanguard Group
Ardsley Advisory Partners
AQR Capital Management
D. E. Shaw & Co
Kingdon Capital Management
Geode Capital Management
Kennedy Capital Management
State Street Corporation
Jacobs Levy Equity Management
Acadian Asset Management
683 Capital Management
Dimensional Fund Advisors

View all funds holding Aldeyra Therapeutics